Sunshine Biopharma, Inc. (SBFM)
NASDAQ: SBFM · Real-Time Price · USD
2.230
-0.120 (-5.11%)
Nov 20, 2026, 4:00 PM EST - Market closed
Sunshine Biopharma Revenue
Sunshine Biopharma had revenue of $9.44M in the quarter ending September 30, 2026, with 0.27% growth. This brings the company's total for the last twelve months to $35.37M, down -5.23% year-over-year. In the year 2025, Sunshine Biopharma had annual revenue of $36.31M with 4.11% growth. That makes Sunshine Biopharma the 30,372nd largest company in the world by revenue and 4,005th in the United States.
Revenue (ttm)
$35.37M
Revenue Growth
-5.23%
P/S Ratio
0.05
Revenue / Employee
$707,438
Employees
50
Market Cap
1.84M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 36.31M | 1.43M | 4.11% |
| Dec 31, 2024 | 34.87M | 10.78M | 44.75% |
| Dec 31, 2023 | 24.09M | 19.75M | 454.42% |
| Dec 31, 2022 | 4.35M | 4.12M | 1,802.41% |
| Dec 31, 2021 | 228.43K | 157.02K | 219.88% |
| Dec 31, 2020 | 71.41K | 50.29K | 238.10% |
| Dec 31, 2019 | 21.12K | - | - |
| Dec 31, 2018 | - | - | - |
| Dec 31, 2017 | - | - | - |
| Dec 31, 2016 | - | - | - |
| Dec 31, 2015 | 1.71K | - | - |
| Dec 31, 2014 | - | - | - |
| Dec 31, 2013 | - | - | - |
| Dec 31, 2012 | - | - | - |
| Dec 31, 2011 | - | - | - |
| Dec 31, 2010 | - | - | - |
| Jul 31, 2009 | - | - | - |
| Jul 31, 2008 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Biofrontera | 48.26M |
| IM Cannabis | 32.25M |
| Sonoma Pharmaceuticals | 23.49M |
| cbdMD | 20.93M |
| Universe Pharmaceuticals INC | 17.74M |
| China SXT Pharmaceuticals | 1.14M |
| RedHill Biopharma | 286.00K |
| Gelteq | 240.44K |
SBFM News
- 3 days ago - Sunshine Biopharma to offer 31.09M shares of common stock - TheFly
- 4 weeks ago - Sunshine Biopharma Inc trading halted, news pending - TheFly
- 4 weeks ago - Sunshine Biopharma announces reverse stock split - TheFly
- 4 weeks ago - Sunshine Biopharma Announces Reverse Stock Split to Maintain NASDAQ Listing - Accesswire
- 6 weeks ago - Sunshine Biopharma Announces Closing of up to $20.4 Million Public Offering - Accesswire
- 6 weeks ago - Sunshine Biopharma prices $6.0M public offering - TheFly
- 6 weeks ago - Sunshine Biopharma Inc. Announces Pricing of $6.0 Million Public Offering - Accesswire
- 7 weeks ago - Sunshine Biopharma files to sell 10.18M common units - TheFly